<SEC-DOCUMENT>0001144204-14-063517-index.html : 20141029
<SEC-HEADER>0001144204-14-063517.hdr.sgml : 20141029
<ACCEPTANCE-DATETIME>20141029110150
ACCESSION NUMBER:		0001144204-14-063517
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20141024
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141029
DATE AS OF CHANGE:		20141029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akers Biosciences Inc
		CENTRAL INDEX KEY:			0001321834
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36268
		FILM NUMBER:		141179060

	BUSINESS ADDRESS:	
		STREET 1:		201 GROVE RD
		CITY:			THOROFARE
		STATE:			NJ
		ZIP:			08086
		BUSINESS PHONE:		856-848-8698

	MAIL ADDRESS:	
		STREET 1:		201 GROVE RD
		CITY:			THOROFARE
		STATE:			NJ
		ZIP:			08086
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v392328_8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: v392328_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v392328_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
Document 2 - file: v392328_ex10-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v392328_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 3 - file: v392328_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>